Eng Oliver S, Turaga Kiran K
Department of Surgery, University of Chicago, Chicago, Illinois.
J Surg Oncol. 2019 Apr;119(5):613-615. doi: 10.1002/jso.25438. Epub 2019 Mar 10.
As the management of metastatic colorectal cancer (CRC) has evolved over the past decades, optimal management of CRC with peritoneal metastases remains controversial, especially about cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. In this review, we highlight the current data on this challenging disease process, as well as comment on its limitations.
在过去几十年中,转移性结直肠癌(CRC)的治疗方法不断演变,对于伴有腹膜转移的CRC的最佳治疗方案仍存在争议,尤其是在细胞减灭术和腹腔内热灌注化疗方面。在本综述中,我们重点介绍了关于这一具有挑战性疾病进程的当前数据,并对其局限性进行了评论。